Ad
ATAI - ATAI Life Sciences N V Stock Trading
About | ATAI Life Sciences N.V. (NASDAQ:ATAI)
Not available
Quote | ATAI Life Sciences N.V. (NASDAQ:ATAI)
| Last: | $1.28 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $1.31 |
| Close: | $1.28 |
| High: | $1.325 |
| Low: | $1.27 |
| Volume: | 421,148 |
| Last Trade Date Time: | 09/25/2023 03:00:00 am |
News | ATAI Life Sciences N.V. (NASDAQ:ATAI)
-
This June, America’s first-ever service center for psilocybin-assisted therapy opened in Oregon, marking both the state and country’s first definitive steps toward legalizing therapeutic psilocybin for the masses. Oregon is the first state in the country to offer psilocybin-rela...
-
2023-09-19 08:00:18 ET FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – September 19, 2023 – Depression is costing the economy $1 trillion in lost production every single year. Yet, a classical compound that even the FDA has twi...
Message Board Posts | ATAI Life Sciences N.V. (NASDAQ:ATAI)
| Subject | By | Source | When |
|---|---|---|---|
| znewcar1: #Better life via chemistry. $LOBEF, $ATAI, $MNMD, $CYBN | znewcar1 | investorshangout | 02/03/2023 6:41:49 PM |
ATAI Life Sciences N.V. Company Name:
ATAI Stock Symbol:
NASDAQ Market:
ATAI Life Sciences N.V. Website:
Ad
-
Psychedelics are one of the buzziest topics in tech these days. With entrepreneurs vouching for their benefits for creativity, focus and gener...
-
This June, America’s first-ever service center for psilocybin-assisted therapy opened in Oregon, marking both the state and country’s first definitive steps toward legalizing therapeutic psilocybin for the masses. Oregon is the first state in the country to offer psilocybin-rela...
-
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next MAPS Public Benefit Corporation (MAPS PBC), the nonprofi...